# Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer

> **NCT00004186** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 55 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** etoposide
- **DRUG:** ifosfamide
- **DRUG:** topotecan hydrochloride
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00004186
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-12
- **Primary completion:** 2004-12
- **Final completion:** 2004-12
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2013-04-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004186, "Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00004186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*